Evidence in favour
- Participation spans 7 named insiders rather than one filing source.
Company insider dossier
MiMedx Group Inc insider intelligence
MDXG filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
48/100
Balanced insider tape
56/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Latest evidence
- 2 Jul 2026
Investment committee read
Balanced insider tape
Acquisition and disposal evidence is mixed after low-information compensation and derivative activity is separated out.
Wait for clearer clusteringDecision risks
- Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
- The latest qualifying filing is more than 30 days old.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Feb 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 4.34 USD
- One-week move
- +5.1%
- Four-week move
- +5.6%
- Fair-value gap
- -35.3%
- Trend signal
- Inactive
- Relative strength
- -30.4
Directional balance
Controlled event mix
33.3%acquisition
- Acquisition events
- 1
- Disposal events
- 2
- Net value
- $800.3K
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
025 May
001 Jun
508 Jun
015 Jun
122 Jun
129 Jun
006 Jul
013 Jul
020 Jul
027 Jul
003 Aug
010 Aug
Named participants
Insider conviction by person
BIERMAN, JAMES LDirector721 events
HAWKINS, WILLIAM ADirector721 events
NEWTON, TODDDirector721 events
OLSON, TIFFANYDirector721 events
PUHY, DOROTHY EDirector721 events
DOUG, RICEChief Financial Officer281 events
MAERSK-MOLLER, KIMBERLYChief Commercial Officer281 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable MDXG filing ledger
Showing 1 to 7 of 7.
DOUG, RICEChief Financial Officer
DisposalCommon equity
12749 sharesCommon Stock
$50.4KDirectional evidence
MAERSK-MOLLER, KIMBERLYChief Commercial Officer
DisposalCommon equity
19820 sharesCommon Stock
$75.9KDirectional evidence
BIERMAN, JAMES LDirector
AcquisitionCommon equity
50913 sharesCommon Stock
$185.3KDirectional evidence
HAWKINS, WILLIAM ADirector
AcquisitionCommon equity
50913 sharesCommon Stock
$185.3KDirectional evidence
NEWTON, TODDDirector
AcquisitionCommon equity
50913 sharesCommon Stock
$185.3KDirectional evidence
OLSON, TIFFANYDirector
AcquisitionCommon equity
50913 sharesCommon Stock
$185.3KDirectional evidence
PUHY, DOROTHY EDirector
AcquisitionCommon equity
50913 sharesCommon Stock
$185.3KDirectional evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.